Citation Tools

Download PDFPDF

201 Carboplatin, paclitaxel and pembrolizumab for the first line treatment of recurrent and/or metastatic head and neck squamous cell carcinoma

Download to a citation manager

Cite this article as:
Valadez A, Welsh M, Kim C, et al
201 Carboplatin, paclitaxel and pembrolizumab for the first line treatment of recurrent and/or metastatic head and neck squamous cell carcinoma